ERAS Compliance and Nutritional Outcomes After Lung Cancer Surgery

NCT07785791 | Recruiting

• 1 other identifier: EU02
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

This prospective observational study will evaluate the association between ERAS protocol compliance and postoperative nutritional outcomes in 120 patients undergoing lung cancer surgery. ERAS compliance will be recorded, and patients will be classified as having high, moderate, or low compliance. NRS-2002 and PNI will be assessed before surgery and at postoperative 48 hours. Hospital stay and postoperative complications will also be evaluated.

Conditions

Lung Cancer

Keywords

Enhanced Recovery After Surgery; ERAS Compliance; Nutritional Risk; Prognostic Nutritional Index; NRS-2002; Thoracic Surgery

Outcome Measures

Primary Outcomes (1)

• Change in Nutritional Risk Screening 2002 Score

  NRS-2002 will be assessed before surgery and at postoperative 48 hours. The score ranges from 0 to 7, with higher scores indicating greater nutritional risk. Change will be calculated as the postoperative score minus the preoperative score.

  From preoperative assessment to 48 hours after surgery

Secondary Outcomes (4)

• Change in Prognostic Nutritional Index

  From preoperative assessment to 48 hours after surgery

• Length of Hospital Stay

  From surgery to hospital discharge, assessed up to 30 days

• Postoperative Complications

  From surgery to 30 days after surgery

• ERAS Protocol Compliance

  Perioperative/Periprocedural

Study Arms (3)

High ERAS Compliance

Patients with an overall ERAS protocol compliance rate of 80% or greater.

Other: Routine ERAS Perioperative Care

Moderate ERAS Compliance

Patients with an overall ERAS protocol compliance rate between 60% and 79%.

Other: Routine ERAS Perioperative Care

Low ERAS Compliance

Patients with an overall ERAS protocol compliance rate below 60%.

Other: Routine ERAS Perioperative Care

Interventions

Routine ERAS Perioperative Care OTHER

Patients receive routine perioperative care according to the institutional ERAS protocol. No intervention is assigned by the investigators. ERAS compliance is assessed observationally.

High ERAS Compliance; Low ERAS Compliance; Moderate ERAS Compliance

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients undergoing elective lung cancer surgery at Bursa City Hospital.

You may qualify if:

• Age between 18 and 85 years
• Scheduled for elective lung cancer surgery under general anesthesia
• ASA physical status I-III
• Able to provide written informed consent

You may not qualify if:

• Emergency surgery
• Preoperative total parenteral nutrition
• Advanced organ failure
• Uncontrolled metabolic disease
• Pregnancy or breastfeeding
• Inability to provide informed consent

Sponsors & Collaborators

• Bursa City Hospital: lead

Study Sites (1)

Bursa City Hospital

Bursa, Nilüfer, 16110, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Central Study Contacts

emre ulusoy, MD

CONTACT

05379492799; emreulusoy36@gmail.com

Emre ULUSOY

CONTACT

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD

Study Record Dates

• First Submitted: August 20, 2026
• First Posted: August 25, 2026
• Study Start: May 15, 2026
• Primary Completion (Estimated): September 7, 2026
• Study Completion (Estimated): October 5, 2026
• Last Updated: August 25, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)